A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03887455 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 25, 2019
Last Update Posted : June 12, 2023
|
Sponsor:
Eisai Inc.
Collaborator:
Biogen
Information provided by (Responsible Party):
Eisai Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 15, 2027 |
| Estimated Study Completion Date : | September 15, 2027 |